SHL Medical - Pharma Technology Focus | Issue 123 | October 2022

Get in touch now

02/24/2024 00:36:03

Home | The promise of billion-dollar KRAS drugs
In this issue
Contents
Wek-tec Company Insight
CSafe Global
Briefing
Industry news
The pharma industry briefing
SHL Medical Company Insight
SHL Medical
Agilent
Comment
The potential of virtual reality-based therapy for serious mental disorders
Brazil: an untapped market for big pharma manufacturing
More big wins for the AstraZeneca-Daiichi Sankyo collaboration
Dry powder inhalers carry potential to decrease greenhouse emissions
Black participants severely underrepresented in global oncology studies
Polio outbreak in New York state due to low vaccination coverage
Mimotopes Company Insight
Mimotopes
Skyepharma
In Depth
Exploring the promise of billion-dollar KRAS drugs
Nanorobots: small solutions to big delivery problems
Foreign investments amplify the nucleic acid therapeutics field
Going beyond the mirage of complete skin clearance in psoriasis
As Russia’s clinical trials sector falls, Ukraine rebuilds
CMO Moves: Regulatory catalysts for drug manufacturing—September
Dr. Paul Lohmann
Baxter
In Data
Top pharma companies best positioned to weather industry disruption
Which pharma companies lead the way in artificial intelligence?
North America sees a hiring jump in big data roles in pharma
Cloud computing mentions decrease in pharma filings
Events
Next issue

09/21/2022 00:00:00